2 BIND MOLECULAR INTERACTIONS
LIVE

Serial Number

79330918

Owner

2bind GmbH

Attorney

Elissa A. Tisdahl

Filing Date

Jun 2, 2021

Add to watchlist:

No watchlists yet
View on USPTO

2 BIND MOLECULAR INTERACTIONS Trademark

Serial Number: 79330918 • Registration: 7141196

2 BIND MOLECULAR INTERACTIONS is a trademark filed by 2bind GmbH on June 2, 2021. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

2bind GmbH (5 trademarks)

Am BioPark 11

Entity Type: 27

Trademark Details

Filing Date

June 2, 2021

Registration Date

August 22, 2023

Published for Opposition

June 6, 2023

Goods & Services

Chemical, biochemical and biological agents, compounds, preparations, reagents and substances for scientific, research, laboratory purposes, other than for medical or veterinary purposes; chemical, biochemical and biological preparations for use in biophysical and biotechnological, scientific, research, laboratory, industrial, and commercial process; diagnostic reagents, buffers, buffer solutions, buffer-screening stock solutions, bioliquids, ligands, therapeutic antibodies, monoclonal antibodies, antibody reagents, proteins, aptamers, antigens, and biochemicals for in vitro and in vivo applications for scientific, research, laboratory purposes, all the aforesaid except for medical and veterinary purposes; chemical, biochemical and biological agents, compounds, preparations, reagents and substances for the development, manufacture and research of pharmaceutical preparation, medicines, medicine products, medical diagnostics, diagnostic and analysis products, food, cosmetics, cleaning preparation and disinfectants in the fields of biology, biotechnology, biochemistry, chemistry, pharmacy and cosmetics, other than for medical or veterinary purposes; chemical, biochemical and biological preparations for the development, manufacture and research of biophysical and biotechnological pharmaceutical preparation, medicines, medical products, medical diagnostics, diagnostic and analysis products, food, cosmetics, cleaning preparations, and disinfectants

Scientific services, namely, conducting of biophysical interaction analyses by means of microscale thermophoresis technology for determining binding parameters of molecular interactions; scientific laboratory services, namely, plasmid cloning, protein expression in E. coli, protein purification and fluorescent protein marking; scientific and technological services, namely, scientific research, analysis, testing in the field of biophysical analytics; research and development services in the fields of pharmacy, biology, molecular biology, genetic science, biochemistry, biotechnology, chemistry, food industry and cosmetics; medical and pharmaceutical research and development; scientific, technological and industrial biochemical analysis and research; scientific laboratory services; scientific research laboratory services; analytical scientific laboratory services; conducting of scientific experiments and tests, namely, testing of pharmaceuticals, cosmetics, foodstuff, medical products, medical diagnostics, diagnostic, and analysis products; consultancy in the field of scientific, industrial and technological research and development in the pharmaceutical, medicinal, cosmetics, food stuff, and biotechnology fields; conducting of technical scientific feasibility studies; development of industrial processes, namely, development of testing specifications and procedures in the field of biophysical analytics; development of new products; development of new technology for others in the field of biophysical analytics; services for the development of methods of testing in the fields of pharmaceuticals and vaccines, cosmetics, food stuff, medical products, medical diagnostics, diagnostic and analysis products; research and development services and industrial, scientific and technological laboratory services in the field of protein and RNA-based medicine development, antibody development, protein analysis, aptamer development and the determination of molecular interactions

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 30, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 30, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 30, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 30, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 30, 2024 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 11, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 22, 2023 FICS
FINAL DISPOSITION PROCESSED
Nov 22, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 22, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 22, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 22, 2023 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 3, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 18, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 14, 2023 OPNR
NOTIFICATION PROCESSED BY IB
Jun 6, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 6, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 17, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 17, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 17, 2023 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 4, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 23, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 22, 2023 ERFR
ASSIGNED TO EXAMINER
Mar 6, 2023 DOCK
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 6, 2023 GNFN
FINAL REFUSAL E-MAILED
Mar 6, 2023 GNFR
FINAL REFUSAL WRITTEN
Mar 6, 2023 CNFR
ASSIGNED TO EXAMINER
Feb 21, 2023 DOCK
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 7, 2022 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 22, 2022 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 8, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 31, 2022 TROA
ASSIGNED TO EXAMINER
May 17, 2022 DOCK
REFUSAL PROCESSED BY IB
Apr 11, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 21, 2022 RFCS
REFUSAL PROCESSED BY MPU
Mar 21, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 18, 2022 RFCR
NON-FINAL ACTION WRITTEN
Feb 17, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 17, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 18, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 13, 2022 REPR